Abstract: The present invention relates to a stable GLP-2 peptide injectable composition, comprising GLP-2 peptide agent comprises of sodium; wherein the GLP-2 peptide agent is teduglutide or h[Gly2]GLP-2 and one or more pharmaceutically acceptable excipient(s).
| # | Name | Date |
|---|---|---|
| 1 | 202547041387-REQUEST FOR EXAMINATION (FORM-18) [29-04-2025(online)].pdf | 2025-04-29 |
| 2 | 202547041387-POWER OF AUTHORITY [29-04-2025(online)].pdf | 2025-04-29 |
| 3 | 202547041387-FORM 18 [29-04-2025(online)].pdf | 2025-04-29 |
| 4 | 202547041387-FORM 1 [29-04-2025(online)].pdf | 2025-04-29 |
| 5 | 202547041387-DECLARATION OF INVENTORSHIP (FORM 5) [29-04-2025(online)].pdf | 2025-04-29 |
| 6 | 202547041387-COMPLETE SPECIFICATION [29-04-2025(online)].pdf | 2025-04-29 |